Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
10.49
-0.01 (-0.10%)
At close: Jul 20, 2026, 4:00 PM EDT
10.29
-0.20 (-1.91%)
After-hours: Jul 20, 2026, 5:33 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $495.48 million as of July 20, 2026. Its market cap has increased by 73.69% in one year.
Market Cap
495.48M
Enterprise Value
425.54M
1-Year Change
73.69%
Ranking
Category
Stock Price
$10.49
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $495.48M, a decrease of -7.97%. That is a compound annual growth rate of -1.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 495.48M | 72.53% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 528.93M |
| Zura Bio | 517.74M |
| Arvinas | 516.81M |
| Ginkgo Bioworks Holdings | 516.72M |
| REGENXBIO | 511.30M |
| Crescent Biopharma | 490.13M |
| ProKidney | 489.34M |
| Sagimet Biosciences | 482.90M |